[144] Progyny, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Progyny, Inc. (PGNY) reports a proposed sale of 599 shares of common stock through Fidelity Brokerage Services on 09/04/2025 with an aggregate market value of $14,094.47. The filing shows these shares were acquired the same day as restricted stock vesting and were paid as compensation. The issuer has 85,982,409 shares outstanding. The filing also discloses a prior sale by the same person: 2,398 shares sold on 08/28/2025 for $55,058.08, identified as seller Allison C. Swartz. The form includes the standard signature representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider proposes a small sale following restricted stock vesting; transaction size is minor versus outstanding shares.

The filing documents a proposed sale of 599 shares valued at $14,094.47 arising from restricted stock vesting and designated as compensation. From an investor-impact perspective, this is routine insider liquidity after vesting rather than a corporate action. The earlier reported sale of 2,398 shares for $55,058.08 indicates ongoing disposition activity by the same individual. Given the issuer's 85,982,409 shares outstanding, these transactions are immaterial to capitalization and unlikely to affect market dynamics on their own. The filing complies with Rule 144 disclosure requirements and includes the standard certification about material nonpublic information.

Corporate Governance Expert

TL;DR: Disclosure is procedurally complete; sales stem from vested compensation and include required representations.

The Form 144 provides requisite details: broker, number of shares, acquisition method (restricted stock vesting), payment nature (compensation), and past three-month sales by the filer. From a governance standpoint, this is a routine compliance filing following equity vesting. The presence of prior sales by the same individual is transparent and appropriately disclosed. No indications of trading-plan dates or 10b5-1 reliance are provided in the document. The filing's signature statement reiterates the filer’s attestation regarding material nonpublic information, fulfilling procedural expectations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	599	14094.47	85982409	09/04/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/04/2025	Restricted Stock Vesting	Issuer			599	09/04/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Allison C. Swartz 1359 Broadway New York NY 10018	Common	08/28/2025	2398	55058.08

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)